Hey. never mind what I just said.about being punk'd. Like gal I knew all along that he was a fake and that's also why I asked for proof too. Yeah, that's the ticket! Like gal, I will not admit to being fooled or to not knowing something ever. LOL.
Saying Oppenheimer advised they will get $25 or $40 is no opinion. You stated a supposed fact. To follow up on gals post, what is your proof that such a statement was made?
The more I read of posts like yours the more convinced I am that this direction that dictates that manufactures develop ADF is a fiasco, unnecessary expense for the pharmaceutical companies and a lessening of quality for the pain patient.
Alkermes acquired Zohydro when it bought a unit of Élan, the developer of Zohydro. Previous to Alkermes purchase and subsequent ownership of Zohydro ER from Élan, Élan made a deal with Zogenix to market Zohydro only in the United States. Then Alkermes entered into a license and distribution agreement with Palladin Labs for rights to sell Zohydro in Canada. Alkermes is the manufacturer of Zohydro for Zogenix (US) and Palladin Labs ( Canada). Endo recently bought Palladin so now Zogenix sells Zohydro only in the US and Endo sells Zohydro only in Canada. Endo gets the profits for Canadian sales. Stating the obvious , Endo and Zogenix are separate companies. Therefore Zogenix does not receive cash in any way for Canadian sales. Alkermes gets the licensing fees for Canadian sales of Zohydro since Alkermes dealt the Canadian rights to Palladin, now owned by Endo.. So IF Endo and Zogenix create a partnership to sell Zohydro, won't the partnership be strictly for United States sales only?. If so, how do Canadian sales of Zohydro benefit the balance sheet of Zogenix in any way? (Maddchicagoan, please weigh in to clear this up. thanks.)
Since gal didn't answer my question and since she said Zogenix cash position would benefit once Zohydro is sold in Canada, I REPEAT the question: Is Zogenix licensed to sell Zohydro in Canada or is Alkermes licensed to sell and benefit from sales of Zohydro ER in Canada?
Madd, is this true? Is Zogenix licensed to sell Zohydro in Canada whether through a partner or direct. Thought they were only licensed to sell in the United States, not North America.
And OxyContin was described as "junk". Lot of scripts being written for something that is supposedly "junk".
If the above is an Adam F opinion piece, I would bet against him. Examples of past opinions from him: September 2013, " Given the FDA's strong actions to crack down on the abuse of long acting opioids, it seems completely illogical for the agency to reverse course and approve Zohydro" and "I am fairly confident that whenever the FDA does get around to deciding Zohydro's fate, the news will be bad." And April 2014: "given the epidemic of narcotic abuse in this country, there is no excuse for introducing a product without proper safeguards." He was strictly referring to ADF technology, which the FDA has stated is not effective, and no mention of the REMS safeguards put in place by the FDA and Zogenix.
Thanks bgreen. Actually I was replying to daddy. Basically I was saying it is difficult to be certain about anything based on what has happened to this company over the last couple years.
How can you be so sure when pretty much everyone who is positive about ZGNX believed there was little chance the 120 mg hydro NDA would be approved , let alone fast tracked? After all, it meets two concerns being pushed by the FDA, no acetominophen and ADF. And it doesn't matter that those knowledgeable about these things know the ADF is ineffective. Politicians, the press and public opinion will celebrate it. And pain patients should feel great that more manufacturers, like Zo, Teva and Purdue, are making opioids without acetominophen.